Trial intelligence / Profile preview

Effect of metformin on endometrial gene expression in PCOS women with and without impaired glucose tolerance

TCTR20250219008Completed

Sponsor
N/A
Start
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Trial of metformin in polycystic ovary syndrome (PCOS) and prediabetes (2 arms), sponsored by N/A. Primary endpoint: Change in endometrial gene expression with metformin exposure. Started Jan 2024; status: completed.

02

Drugs

metformin
03

Conditions

polycystic ovary syndrome (PCOS)prediabetes

Beyond the preview

Go deeper on TCTR20250219008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250219008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call